Sofie Joossens

3.2k total citations
45 papers, 2.3k citations indexed

About

Sofie Joossens is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Sofie Joossens has authored 45 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 22 papers in Epidemiology and 14 papers in Immunology. Recurrent topics in Sofie Joossens's work include Inflammatory Bowel Disease (27 papers), Microscopic Colitis (17 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). Sofie Joossens is often cited by papers focused on Inflammatory Bowel Disease (27 papers), Microscopic Colitis (17 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). Sofie Joossens collaborates with scholars based in Belgium, United States and France. Sofie Joossens's co-authors include Séverine Vermeire, Robert Vlietinck, Kristel Van Steen, Xavier Bossuyt, Marc Peeters, Paul Rutgeerts, Gert Van Assche, Maja Noman, Nele Van Schuerbeek and Nele Esters and has published in prestigious journals such as Gastroenterology, Gut and Clinical Chemistry.

In The Last Decade

Sofie Joossens

45 papers receiving 2.2k citations

Peers

Countries citing papers authored by Sofie Joossens

Since Specialization

Citations

This map shows the geographic impact of Sofie Joossens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Joossens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Joossens more than expected).

Fields of papers citing papers by Sofie Joossens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Joossens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Joossens. The network helps show where Sofie Joossens may publish in the future.

Co-authorship network of co-authors of Sofie Joossens

This figure shows the co-authorship network connecting the top 25 collaborators of Sofie Joossens. A scholar is included among the top collaborators of Sofie Joossens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofie Joossens. Sofie Joossens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Resilience in advanced cancer caregiving promoted by an intimate partner’s support network: insights through the lens of complexity science. A framework analysis 2023 ·BMC Palliative Care ·(unknown), Sofie Joossens, Emelien Lauwerier, Jan De Lepeleire, Peter Pype	2
2	Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease 2008 ·European Journal of Pediatrics ·Mirjam Bueno de Mesquita, Marc Ferrante, Liesbet Henckaerts, Marie Joossens, (unknown), Tibor Hlavatý, (unknown), Sofie Joossens, Nele Van Schuerbeek, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire, Ilse Hoffman	8
3	Detection of Antisynthetic Mannoside Antibodies (AΣMA) Reveals Heterogeneity in the ASCA Response of Crohn's Disease Patients and Contributes to Differential Diagnosis, Stratification, and Prediction 2008 ·The American Journal of Gastroenterology ·(unknown), Jean–Frédéric Colombel, Sofie Joossens, Annie Standaert‐Vitse, Mayeul Collot, Jonas Halfvarson, Ali Ayadi, Carol J. Landers, Séverine Vermeire, Paul Rutgeerts, Stephan R. Targan, Mathias Chamaillard, Jean‐Maurice Mallet, Boualem Sendid, Daniel Poulain	22
4	Familial Crohn's Disease in Belgium 2007 ·Journal of Clinical Gastroenterology ·Herbert J. Van Kruiningen, Marie Joossens, Séverine Vermeire, Sofie Joossens, Stéphane Debeugny, Corinne Gower‐Rousseau, Antoine Cortot, Jean‐Frédéric Colombel, Paul Rutgeerts, Robert Vlietinck	14
5	New serological markers in inflammatory bowel disease are associated with complicated disease behaviour 2007 ·Gut ·Marc Ferrante, Liesbet Henckaerts, Marie Joossens, (unknown), Sofie Joossens, Nir Dotan, (unknown), Rom T. Altstock, Kristel Van Steen, P. Rutgeerts, Gert Van Assche, Séverine Vermeire	234
6	A panel of anti-glycan antibodies (gASCA, ALCA, ACCA and AMCA) in the diagnosis and differential diagnosis of IBD 2006 ·Ghent University Academic Bibliography (Ghent University) ·Marc Ferrante, Marieke Pierik, Liesbet Henckaerts, Nir Dotan, Rom T. Altstock, Iris Dotan, Marie Joossens, Sofie Joossens, Κωνσταντίνος Κατσάνος, Karolien Claes, Nele Van Schuerbeek, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire	1
7	The MDR1 G2677T polymorphism is associated with gastrointestinal intolerance to azathioprine 2006 ·Gastroenterology ·Konstantinos Katsanos, Marc Ferrante, Marie Joossens, Sofie Joossens, Liesbet Henckaerts, Marieke Pierik, Karolien Claes, Nele Van Schuerbeek, Afroditi Katsaraki, Gert Van Assche, Epameinondas V. Tsianos, Paul Rutgeerts, Séverine Vermeire	1
8	Study on CARD15 and TLR4 polymorphisms in children with early diagnosed IBD and their family members 2005 ·Gastroenterology ·(unknown), Liesbet Henckaerts, Marie Joossens, (unknown), Tibor Hlavatý, Marc Ferrante, Rajaraman Eri, Sofie Joossens, Nele Van Schuerbeek, Gert Van Assche, Séverine Vermeire, Ilse Hoffman, Paul Rutgeerts	1
9	Prediction of response to infliximab in luminal and fistulizing Crohn's disease based on a decision making model using an apoptotic pharmacogenetic index and clinical predictors 2005 ·Gastroenterology ·Tibor Hlavatý, Marc Ferrante, Liesbet Henckaerts, Marieke Pierik, Sofie Joossens, (unknown), Paul Rutgeerts, Séverine Vermeire	1
10	Study on DLG5 and OCTN polymorphisms shows association of the OCTN to risk haplotype with perianal and fistulizing Crohn's disease but not with susceptibility to IBD 2005 ·Gastroenterology ·Séverine Vermeire, Marieke Pierik, Liesbet Henckaerts, Tibor Hlavatý, Marc Ferrante, (unknown), Greet Claessens, Nele Van Schuerbeek, Sofie Joossens, Robert Vlietinck, Paul Rutgeerts	2
11	Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease 2005 ·Alimentary Pharmacology & Therapeutics ·Tibor Hlavatý, (unknown), Liesbet Henckaerts, Marc Ferrante, Sofie Joossens, Nele Van Schuerbeek, Maja Noman, P. RUTGEERTS, Séverine Vermeire	153
12	Granulomas, pattern recognition receptors (PRR) and phenotypes of Crohn's disease (CD) 2004 ·Gastroenterology ·Rajaraman Eri, Gert De Hertogh, Séverine Vermeire, Sofie Joossens, Peter Van Eyken, Greet Claessens, Gert Van Assche, Karel Geboes, Paul Rutgeerts	1
13	CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn's disease and selective GCP‐2/CXCL6 expression in inflamed intestinal tissue 2004 ·European Journal of Immunology ·Klara Gijsbers, Gert Van Assche, Sofie Joossens, Sofie Struyf, Paul Proost, Paul Rutgeerts, Karel Geboes, Jo Van Damme	63
14	Tumour necrosis factor‐α receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab 2004 ·Alimentary Pharmacology & Therapeutics ·(unknown), Séverine Vermeire, Kristel Van Steen, Sofie Joossens, Greet Claessens, Robert Vlietinck, P. Rutgeerts	120
15	Transmission of CARD15 (NOD2) Variants Within Families of Patients with Inflammatory Bowel Disease 2004 ·The American Journal of Gastroenterology ·Nele Esters, (unknown), Kristel Van Steen, Séverine Vermeire, Greet Claessens, Sofie Joossens, Robert Vlietinck, Paul Rutgeerts	50
16	Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn’s disease: a prospective cohort study 2003 ·Gastroenterology ·Séverine Vermeire, Maja Noman, Gert Van Assche, Filip Baert, Kristel Van Steen, Nele Esters, Sofie Joossens, Xavier Bossuyt, Paul Rutgeerts	250
17	The value of serologic markers in indeterminate colitis: A prospective follow-up study 2002 ·Gastroenterology ·Sofie Joossens, Walter Reinisch, Séverine Vermeire, Boualem Sendid, Daniel Poulain, Marc Peeters, Karel Geboes, Xavier Bossuyt, Peggy Vandewalle, Georg Oberhuber, Harald Vogelsang, Paul Rutgeerts, Jean–Frédéric Colombel	215
18	Comparative study of ASCA (Anti–Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease 2001 ·Gastroenterology ·Séverine Vermeire, Sofie Joossens, Marc Peeters, (unknown), Godelieve Mariën, Xavier Bossuyt, Peter Groenen, Robert Vlietinck, P. Rutgeerts	120
19	Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease 2001 ·The American Journal of Gastroenterology ·Marc Peeters, Sofie Joossens, Séverine Vermeire, Robert Vlietinck, Xavier Bossuyt, P Rutgeerts	235
20	ASCA and PANCA prevalence in mixed-IBD families 1999 ·Gastroenterology ·Séverine Vermeire, Marc Peeters, (unknown), Sofie Joossens, (unknown), Boualem Sendid, Daniel Poulain, Paul Rutgeerts	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact